Mark Qian - Publications

1996 Chemistry University of Michigan, Ann Arbor, Ann Arbor, MI 

12 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Li C, Dong L, Kamali A, Sugimoto H, Abdul-Hadi K, Chen S, Abu-Yousif A, Qian MG. An LC/MS based method to quantify DNA adduct in tumor and organ tissues. Analytical Biochemistry. PMID 30579655 DOI: 10.1016/j.ab.2018.12.014  0.6
2018 Sugimoto H, Wei D, Dong L, Ghosh D, Chen S, Qian MG. Perspectives on potentiating immunocapture-LC-MS for the bioanalysis of biotherapeutics and biomarkers. Bioanalysis. PMID 30371100 DOI: 10.4155/bio-2018-0205  0.6
2018 Sugimoto H, Ghosh D, Chen S, Smith MD, Abu-Yousif AO, Qian MG. Immunocapture-LC/MS based target engagement measurement in tumor plasma membrane. Analytical Chemistry. PMID 30371057 DOI: 10.1021/acs.analchem.8b03726  0.6
2018 Dong L, Li C, Locuson C, Chen S, Qian MG. A Two-Step Immunocapture LC/MS/MS Assay for Plasma Stability and Payload Migration Assessment of Cysteine-Maleimide-Based Antibody Drug Conjugates. Analytical Chemistry. PMID 29688004 DOI: 10.1021/acs.analchem.8b00694  0.6
2016 Xu L, Packer LE, Qian MG, Wu JT. Rapid quantification of a cleavable antibody-conjugated drug by liquid chromatography/tandem mass spectrometry with microwave-assisted enzymatic cleavage. Journal of Pharmaceutical and Biomedical Analysis. 128: 226-235. PMID 27281578 DOI: 10.1016/j.jpba.2016.05.043  0.4
2016 Gupta N, Hanley MJ, Harvey RD, Badros A, Lipe B, Kukreti V, Berdeja J, Yang H, Hui AM, Qian M, Zhang X, Venkatakrishnan K, Chari A. A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysis. British Journal of Haematology. PMID 27196567 DOI: 10.1111/bjh.14125  0.36
2016 Gupta N, Hanley MJ, Venkatakrishnan K, Perez R, Norris RE, Nemunaitis J, Yang H, Qian MG, Falchook G, Labotka R, Fu S. Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment. British Journal of Clinical Pharmacology. PMID 27121262 DOI: 10.1111/bcp.12991  0.36
2014 Liao D, Chen S, Paton M, Qian MG. Automated non-stepwise preparation of bioanalytical calibration standards and quality controls using an ultra-low volume digitizing liquid dispenser. Rapid Communications in Mass Spectrometry : Rcm. 28: 1215-20. PMID 24760562 DOI: 10.1002/rcm.6894  0.6
2014 Chen S, Zhang J, Liao D, Qian MG. A novel dynamic flush method to reduce column-related carryover. Journal of Chromatographic Science. 52: 950-3. PMID 23899466 DOI: 10.1093/chromsci/bmt111  0.6
2006 Musteata FM, Pawliszyn J, Qian MG, Wu JT, Miwa GT. Determination of drug plasma protein binding by solid phase microextraction. Journal of Pharmaceutical Sciences. 95: 1712-22. PMID 16795010 DOI: 10.1002/jps.20558  0.4
2006 Balani SK, Nagaraja NV, Qian MG, Costa AO, Daniels JS, Yang H, Shimoga PR, Wu JT, Gan LS, Lee FW, Miwa GT. Evaluation of microdosing to assess pharmacokinetic linearity in rats using liquid chromatography-tandem mass spectrometry. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 34: 384-8. PMID 16326814 DOI: 10.1124/dmd.105.007195  0.4
2005 Yu S, Li S, Yang H, Lee F, Wu JT, Qian MG. A novel liquid chromatography/tandem mass spectrometry based depletion method for measuring red blood cell partitioning of pharmaceutical compounds in drug discovery. Rapid Communications in Mass Spectrometry : Rcm. 19: 250-4. PMID 15609367 DOI: 10.1002/rcm.1777  0.4
Show low-probability matches.